DEUDA Cambio Fecha
ALKERMES USD 1.57B 10.58M 2026-09
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 607.23M 3.26M 2026-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
Eisai JPY 254.94B 68.86B 2026-09
Emergent BioSolutions USD 903.2M 495.2M 2023-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 544.86M 180.93M 2026-09
Ligand Pharmaceuticals USD 1.13B 679.48M 2026-06
Merck USD 53.91B 4.79B 2026-06
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 293.59M 69.53M 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Veracyte USD 40.11M 774K 2026-06
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09